GLP-1 RA Use Linked to Lower Rates of Hyperkalemia in Type 2 Diabetes
GLP-1 RAs also linked to lower rates of renin-angiotensin system inhibitor discontinuation than DPP-4i treatment
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.